Abstract
Skin diseases are common public health problems in developing countries.
The prevalence is universal and can cause a significant economic burden. Additionally,
it is a common cause of morbidity among vulnerable groups, such as children, and
affects people of all ages and ethnicities. However, the impact of skin disease on the
national public healthcare system is complex and poorly studied, particularly in
developing countries. A number of factors, including population aging, genetics, and
environment, have contributed to the change in skin disease trends. The combined
effects of these factors have severe health implications for people, and their dynamics
are not fully understood. It is thus necessary to improve diagnostic techniques in order
to provide new therapeutic resources in dermatology in the wake of the scientific
revolution and technological innovations. To understand the changes in the prevalence
of skin disease age-specific distributions and associated mortality, this study provides
comprehensive information on vulnerable populations, epidemiological characteristics,
and geographic distributions. Furthermore, the study provides a baseline for the
management of skin disorders using medicinal plants. Surveillance, burden,
diagnostics, and treatments of skin disease are essential components of developing
measurable, influential, and sustainable intervention programs to reduce disease
infections. Furthermore, these approaches assist in understanding the pathogenesis and
disease process and assist with the development of new therapeutic strategies and preventive measures against morbidity in underdeveloped and developing countries, as well
as establishing a baseline for medicinal plants that contribute significantly to the
treatment.